IHM
ARMO

Iguana Healthcare Management’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Iguana Healthcare Management’s Portfolio ARMO Stock Details ARMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2.25M Buy
+60,000
New +$2.52M 1.48% 30

Other funds holding ARMO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Iguana Healthcare Management's ARMO Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in ARMO BioSciences, Inc. Common Stock (ARMO) in Q1 2018: 60,000 shares worth $2.25M. The stake represents 1.48% of the portfolio and ranks #30 among its holdings.

65 funds tracked by Wall St. Rank hold ARMO as of Q1 2018.

  • Iguana Healthcare Management held 60,000 shares of ARMO BioSciences, Inc. Common Stock worth $2.25M as of Q1 2018.
  • ARMO BioSciences, Inc. Common Stock was a new Iguana Healthcare Management position in Q1 2018.
  • ARMO BioSciences, Inc. Common Stock made up 1.48% of Iguana Healthcare Management's portfolio in Q1 2018, its #30 holding.
  • 65 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.